Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-156429
Filing Date
2024-06-07
Accepted
2024-06-06 21:57:40
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d772410d424b5.htm 424B5 532195
2 GRAPHIC g772410g01g01.jpg GRAPHIC 46536
3 GRAPHIC g772410g79k26.jpg GRAPHIC 27498
  Complete submission text file 0001193125-24-156429.txt   630794
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-278246 | Film No.: 241027108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)